Substance P prevents 1-methyl-4-phenylpyridinium-induced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells

Wang,Shuang‑Yan; Chen,Lei; Xue,Yan; Xia,Yu‑Jun

doi:10.3892/mmr.2015.4464

Substance P prevents 1-methyl-4-phenylpyridinium-induced cytotoxicity through inhibition of apoptosis via neurokinin-1 receptors in MES23.5 cells

Authors:
- Shuang‑Yan Wang
- Lei Chen
- Yan Xue
- Yu‑Jun Xia
View Affiliations

Affiliations: Department of Physiology, Qingdao University, Qingdao, Shandong 266071, P.R. China, Department of Anatomy, Qingdao University, Qingdao, Shandong 266071, P.R. China
Published online on: October 21, 2015 https://doi.org/10.3892/mmr.2015.4464
Pages: 8085-8092

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

[Sar9, Met(O2)11] termed Substance P (SP), is an effective and selective agonist for the neurokinin‑1 (NK‑1) receptors, which are synthetic peptides, similar in structure to SP. SP is an important neurotransmitter or neuromodulator mediated by neurokinin receptors, namely the SP receptor in the central nervous system. The excitatory effects induced by SP may be selectively inhibited by a neurokinin‑1 receptor antagonist, such as SR140333B. It has been proposed that Parkinson's disease (PD) is primarily caused by the loss of trophic peptidergic neurotransmitter, possibly SP, which may lead to the degeneration of neurons. In previous studies, 1‑methyl‑4‑phenylpyridinium (MPP+) has been frequently utilized to establish animal or cell models of PD. In the present study, to further investigate the effects of SP in PD, MPP+ was employed to investigate the promising anti‑apoptotic effects of SP, and examine the underlying mechanisms of the pathology in the MES23.5 dopaminergic cell line. The results indicated that MPP+‑triggered apoptosis was prevented by treatment with SP. SP treatment also decreased the MPP+‑triggered Ca2+ influx, caspase‑3 re‑activity, reactive oxygen species production and mitochondrial membrane potential decrease. Treatment with MPP+ also induced phosphorylation of c‑Jun N‑terminal kinase and p38 mitogen‑activated protein kinase. In addition, treatment with SP inhibited the MPP+‑triggered neurotoxicity in MES23.5 cells. However, no changes were observed in SR140333B+SP+MPP+‑treated MES23.5 cell lines. In conclusion, SP could protect the cells from MPP+‑induced cytotoxicity by inhibiting the apoptosis via NK-1 receptors.

View Figures

View References

1	Li DW, Liu ZQ, Chen W, Yao M and Li GR: Association of glycogen synthase kinase-3β with Parkinson's disease (review). Mol Med Rep. 9:2043–2050. 2014.PubMed/NCBI
2	Obeso JA, Rodríguez-Oroz MC, Rodríguez M, Lanciego JL, Artieda J, Gonzalo N and Olanow CW: Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23(Suppl): S8–S19. 2000. View Article : Google Scholar : PubMed/NCBI
3	Oertel WH and Ellgring H: Parkinson's disease - medical education and psychosocial aspects. Patient Educ Couns. 26:71–79. 1995. View Article : Google Scholar : PubMed/NCBI
4	Levy OA, Malagelada C and Greene LA: Cell death pathways in Parkinson's disease: Proximal triggers, distal effectors, and final steps. Apoptosis. 14:478–500. 2009. View Article : Google Scholar : PubMed/NCBI
5	Irrcher I and Park DS: Parkinson's disease: To live or die by autophagy. Sci Signal. 2:pe212009. View Article : Google Scholar : PubMed/NCBI
6	Hartmann A and Hirsch EC: Parkinson's disease. The apoptosis hypothesis revisited. Adv Neurol. 86:143–153. 2001.PubMed/NCBI
7	Tatton WG, Chalmers-Redman R, Brown D and Tatton N: Apoptosis in Parkinson's disease: Signals for neuronal degradation. Ann Neurol. 53(Suppl 3): S61–S72. 2003. View Article : Google Scholar : PubMed/NCBI
8	Chang WA, Lin ES, Tsai MJ, Huang MS and Kuo PL: Isolinderalactone inhibits proliferation of A549 human non small cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway. Mol Med Rep. 9:1653–1659. 2014.PubMed/NCBI
9	Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC and Agid Y: Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 12:25–31. 1997.PubMed/NCBI
10	Fornai F, Lenzi P, Gesi M, Soldani P, Ferrucci M, Lazzeri G, Capobianco L, Battaglia G, De Blasi A, Nicoletti F, et al: Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J Neurochem. 88:114–123. 2004. View Article : Google Scholar
11	Yakhine-Diop SM, Bravo-San Pedro JM, Gómez-Sánchez R, Pizarro-Estrella E, Rodríguez-Arribas M, Climent V, Aiastui A, López de Munain A, Fuentes JM and González-Polo RA: G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy. Toxicology. 324:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
12	Robinson P, Garza A, Moore J, Eckols TK, Parti S, Balaji V, Vallejo J and Tweardy DJ: Substance P is required for the pathogenesis of EMCV infection in mice. Int J Clin Exp Med. 2:76–86. 2009.PubMed/NCBI
13	Barker R: Tachykinins, neurotrophism and neurodegenerative diseases: A critical review on the possible role of tachykinins in the aetiology of CNS diseases. Rev Neurosci. 7:187–214. 1996. View Article : Google Scholar : PubMed/NCBI
14	Thornton E and Vink R: Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease. PLoS One. 7:e341382012. View Article : Google Scholar : PubMed/NCBI
15	Nalivaiko E, Michaud JC, Soubrié P, Le Fur G and Feltz P: Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: An in vitro electrophysiological study. Neuroscience. 78:745–757. 1997. View Article : Google Scholar : PubMed/NCBI
16	Strell C, Sievers A, Bastian P, Lang K, Niggemann B, Zänker KS and Entschladen F: Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes. BMC Immunol. 10:622009. View Article : Google Scholar : PubMed/NCBI
17	Crawford GD Jr, Le WD, Smith RG, Xie WJ, Stefani E and Appel SH: A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci. 12:3392–3398. 1992.PubMed/NCBI
18	Liu L, Xu H, Jiang H, Wang J, Song N and Xie J: Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells. Exp Neurol. 222:25–29. 2010. View Article : Google Scholar
19	Yao G, Yang L, Hu Y, Liang J, Liang J and Hou Y: Nonylphenol-induced thymocyte apoptosis involved caspase-3 activation and mitochondrial depolarization. Mol Immunol. 43:915–926. 2006. View Article : Google Scholar
20	Feng Z and Zhang JT: Protective effect of melatonin on b-amyloid induced apoptosis in rat astroglioma c6 cells and its mechanism. Free Radic Biol Med. 2004:1790–1801. 2014.
21	Wei CD, Li Y, Zheng HY, Tong YQ and Dai W: Palmitate induces H9c2 cell apoptosis by increasing reactive oxygen species generation and activation of the ERK1/2 signaling pathway. Mol Med Rep. 7:855–861. 2013.PubMed/NCBI
22	Zhao L, Teng B, Wen L, Feng Q, Wang H, Li N, Wang Y and Liang Z: mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma. Int J Clin Exp Med. 7:337–347. 2014.PubMed/NCBI
23	Egnatchik RA, Leamy AK, Jacobson DA, Shiota M and Young JD: ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Mol Metab. 3:544–553. 2014. View Article : Google Scholar : PubMed/NCBI
24	Wang XJ and Xu JX: Possible involvement of Ca²⁺ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett. 376:127–132. 2005. View Article : Google Scholar : PubMed/NCBI
25	Bhattacharyya S, Ghosh S, Shant J, Ganguly NK and Majumdar S: Role of the W07-toxin on Vibrio cholerae-induced diarrhoea. Biochim Biophys Acta. 1670:69–80. 2004. View Article : Google Scholar : PubMed/NCBI
26	Wang J, Du XX, Jiang H and Xie JX: Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol. 78:178–183. 2009. View Article : Google Scholar : PubMed/NCBI
27	Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K and Shiojima T: Trophic effect of various neuropeptides on the cultured ventral spinal cord of rat embryo. Neurosci Lett. 101:316–320. 1989. View Article : Google Scholar : PubMed/NCBI
28	Bleiblo F, Michael P, Brabant D, Ramana CV, Tai T, Saleh M, Parrillo JE and Kumar A and Kumar A: JAK kinases are required for the bacterial RNA and poly I:C induced tyrosine phosphorylation of PKR. Int J Clin Exp Med. 6:16–25. 2013.
29	Kitamura Y, Shimohama S, Akaike A and Taniguchi T: The parkinsonian models: Invertebrates to mammals. Jpn J Pharmacol. 84:237–243. 2000. View Article : Google Scholar
30	Siddique YH, Naz F and Jyoti S: Effect of curcumin on lifespan, activity pattern, oxidative stress, and apoptosis in the brains of transgenic Drosophila model of Parkinson's disease. BioMed Res Int. 606928:20142014.
31	Zhang Z, Zhang K, Du X and Li Y: Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration. Mol Med Rep. 5:562–566. 2012.
32	Ekshyyan O and Aw TY: Apoptosis: A key in neurodegenerative disorders. Curr Neurovasc Res. 1:355–371. 2004. View Article : Google Scholar
33	Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:43–50. 1998. View Article : Google Scholar : PubMed/NCBI
34	Beal MF: Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann Neurol. 44(Suppl 1): S110–S114. 1998. View Article : Google Scholar : PubMed/NCBI
35	Ma S, Cai C, Ma Y, Bai Z, Meng X, Yang X, Zou F and Ge R: Store-operated Ca²⁺ entry mediated regulation of polarization in differentiated human neutrophil-like HL-60 cells under hypoxia. Mol Med Rep. 9:819–824. 2014.PubMed/NCBI
36	Kim HY, LaVaute T, Iwai K, Klausner RD and Rouault TA: Identification of a conserved and functional iron-responsive element in the 5'-untranslated region of mammalian mitochondrial aconitase. J Biol Chem. 271:24226–24230. 1996. View Article : Google Scholar : PubMed/NCBI
37	Scorrano L, Oakes SA, Opferman JT, Cheng EH, Sorcinelli MD, Pozzan T and Korsmeyer SJ: BAX and BAK regulation of endoplasmic reticulum Ca²⁺: A control point for apoptosis. Science. 300:135–139. 2003. View Article : Google Scholar : PubMed/NCBI
38	Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, Wessig J, Waetzig V, Goetz M, Claussen M, et al: Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci. 21:363–377. 2005. View Article : Google Scholar : PubMed/NCBI
39	Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
40	Eminel S, Roemer L, Waetzig V and Herdegen T: c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. J Neurochem. 104:957–969. 2008. View Article : Google Scholar
41	Yeste-Velasco M, Folch J, Casadesús G, Smith MA, Pallàs M and Camins A: Neuroprotection by c-Jun NH2-terminal kinase inhibitor SP600125 against potassium deprivation-induced apoptosis involves the Akt pathway and inhibition of cell cycle reentry. Neuroscience. 159:1135–1147. 2009. View Article : Google Scholar : PubMed/NCBI
42	Hsu MJ, Hsu CY, Chen BC, Chen MC, Ou G and Lin CH: Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis. J Neurosci. 27:5719–5729. 2007. View Article : Google Scholar : PubMed/NCBI
43	Liu XW, Ji EF, He P, Xing RX, Tian BX and Li XD: Protective effects of the p38 MAPK inhibitor SB203580 on NMDA induced injury in primary cerebral cortical neurons. Mol Med Rep. 10:1942–1948. 2014.PubMed/NCBI